CSMCX
Price
$55.57
Change
+$0.67 (+1.22%)
Updated
Jun 2 closing price
Net Assets
2B
WCMNX
Price
$14.98
Change
+$0.18 (+1.22%)
Updated
Jun 2 closing price
Net Assets
53.09M
Interact to see
Advertisement

CSMCX vs WCMNX

Header iconCSMCX vs WCMNX Comparison
Open Charts CSMCX vs WCMNXBanner chart's image
CSMCX vs WCMNX Comparison Chart in %
View a ticker or compare two or three
VS
CSMCX vs. WCMNX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSMCX is a Buy and WCMNX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CSMCX has more cash in the bank: 2B vs. WCMNX (53.1M). CSMCX (0.00) and WCMNX (0.00) have matching dividends . CSMCX was incepted earlier than WCMNX: CSMCX (27 years) vs WCMNX (7 years). WCMNX (2.04) is less costly to investors than CSMCX (1.07). WCMNX is a more actively managed with annual turnover of: 89.00 vs. CSMCX (34.00). WCMNX has a lower initial minimum investment than CSMCX: WCMNX (1000) vs CSMCX (100000). WCMNX annual gain was more profitable for investors over the last year : 25.42 vs. CSMCX (21.92). CSMCX return over 5 years is better than : 27.56 vs. WCMNX (-1.40).
CSMCXWCMNXCSMCX / WCMNX
Total Expense Ratio1.011.2481%
Annual Report Gross Expense Ratio1.072.0452%
Fund Existence27 years7 years-
Gain YTD12.5239.225136%
Front LoadN/AN/A-
Min. Initial Investment100000100010,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2B53.1M3,763%
Annual Yield % from dividends0.000.00-
Returns for 1 year21.9225.4286%
Returns for 3 years49.4331.21158%
Returns for 5 years27.56-1.40-1,970%
Returns for 10 years144.43N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IILGX32.710.13
+0.40%
Thrivent Global Stock S
BLDRX9.740.01
+0.10%
BlackRock Managed Income K
RYENX313.96N/A
N/A
Rydex Energy A
FPACX45.31N/A
N/A
FPA Crescent
NSCCX43.02N/A
N/A
Nuveen Small-Cap Value Opps C